Skip Therapeutics
@skiptx.com
SKIP Therapeutics develops RNA-based therapies for rare genetic disorders and common diseases – utilizing a proprietary computational discovery engine to optimize target selection and therapeutic design.
Skip Therapeutics's Company Logos
Skip Therapeutics's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#0067B2
Endeavour
0, 103, 178
205, 100, 35
100, 42, 0, 30
#A3D9F6
Sail
163, 217, 246
201, 82, 80
34, 12, 0, 4
#003F6B
Regal Blue
0, 63, 107
205, 100, 21
100, 41, 0, 58
About Skip Therapeutics
SKIP Therapeutics is at the forefront of developing RNA-based therapies for rare genetic disorders and common diseases. Leveraging a proprietary computational discovery engine, Skip Therapeutics optimizes target selection for therapeutic design. The brand utilizes Antisense Oligonucleotides (ASO) to restore the function of mutated genes in rare genetic disorders and modify key genes in major disease pathways.
ASOs are designed to precisely bind regulatory regions on RNA, inducing changes in RNA-splicing, expression, and functionality. The innovative computational discovery engine, combined with strong experimental capabilities, sets Skip apart in the realm of RNA-based therapies. With a team of experts and a groundbreaking workflow, Skip Therapeutics continues to unlock therapeutic potential by merging computation and RNA, offering hope for patients worldwide.
Contact SKIP Therapeutics today to learn more about their revolutionary approach to treating genetic disorders and common diseases
Company type
Partnership
Year founded
2021
Company size
2-10 employees
